Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$7.04 - $11.7 $60,163 - $99,988
-8,546 Closed
0 $0
Q3 2020

Jun 26, 2023

BUY
$9.98 - $18.04 $85,289 - $154,169
8,546 New
8,546 $91,000
Q2 2020

Jun 26, 2023

BUY
$7.49 - $15.16 $64,009 - $129,557
8,546 New
8,546 $129,000
Q1 2020

Jul 12, 2023

BUY
$4.62 - $18.74 $39,482 - $160,152
8,546 New
8,546 $71,000
Q1 2020

Mar 30, 2023

BUY
$4.62 - $18.74 $3,210 - $13,024
695 Added 8.85%
8,546 $71,000
Q1 2020

May 15, 2020

BUY
$4.62 - $18.74 $3,210 - $13,024
695 Added 8.85%
8,546 $71,000
Q4 2019

Jul 12, 2023

BUY
$14.6 - $18.13 $114,624 - $142,338
7,851 New
7,851 $132,000
Q4 2019

Mar 30, 2023

SELL
$14.6 - $18.13 $12,789 - $15,881
-876 Reduced 10.04%
7,851 $132,000
Q4 2019

Feb 14, 2020

SELL
$14.6 - $18.13 $12,789 - $15,881
-876 Reduced 10.04%
7,851 $133,000
Q3 2019

Jul 12, 2023

BUY
$16.62 - $23.92 $145,042 - $208,749
8,727 New
8,727 $162,000
Q2 2019

Jul 12, 2023

BUY
$17.79 - $22.88 $155,253 - $199,673
8,727 New
8,727 $199,000
Q1 2019

Jul 13, 2023

BUY
$11.76 - $22.15 $102,629 - $193,303
8,727 New
8,727 $183,000
Q1 2019

Mar 30, 2023

BUY
$11.76 - $22.15 $102,629 - $193,303
8,727 New
8,727 $183,000
Q1 2019

May 16, 2019

SELL
$11.76 - $22.15 $72,159 - $135,912
-6,136 Reduced 41.28%
8,727 $183,000
Q1 2019

May 15, 2019

BUY
$11.76 - $22.15 $72,159 - $135,912
6,136 Added 70.31%
14,863 $953,000
Q4 2018

Jul 13, 2023

BUY
$10.42 - $21.94 $90,935 - $191,470
8,727 New
8,727 $100,000
Q4 2018

Feb 14, 2019

BUY
$10.42 - $21.94 $69,855 - $147,085
6,704 Added 331.39%
8,727 $100,000
Q3 2018

Jul 13, 2023

BUY
$20.4 - $24.6 $178,030 - $214,684
8,727 New
8,727 $200 Million
Q3 2018

Nov 14, 2018

SELL
$20.4 - $24.6 $136,761 - $164,918
-6,704 Reduced 76.82%
2,023 $46,000
Q4 2017

Feb 15, 2018

SELL
$18.0 - $30.0 $145,062 - $241,770
-8,059 Reduced 48.01%
8,727 $229,000
Q2 2017

Aug 14, 2017

BUY
N/A
16,786
16,786 $459,000

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $115M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.